Propanc Biopharma
PPCB · NASDAQ
$0.321+$0.004 (+1.26%)TodayMarket closed ·
Prev close $0.317
Who owns PPCB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 69.1% of PPCB’s shares.
- Nathanielsz (James Andrew)26.3%
- Nathanielsz (Sylvia)22.9%
- Zelinger (Josef)7.0%
- Kingsley (Jeannine)3.6%
- Next 6 largest institutions9.3%
- All other shareholders30.9%
| Holder | Shares | % of shares |
|---|---|---|
| Nathanielsz (James Andrew) | 600.00K | 26.32% |
| Nathanielsz (Sylvia) | 522.00K | 22.89% |
| Zelinger (Josef) | 160.01K | 7.02% |
| Kingsley (Jeannine) | 82.00K | 3.60% |
| Himy (Joseph) | 81.99K | 3.60% |
| Brandt (Ralf Ph.D.) | 80.30K | 3.52% |
| Jane Street Capital, L.L.C. | 25.55K | 1.12% |
| Citadel Advisors LLC | 12.09K | 0.53% |
| HRT Financial LP | 10.24K | 0.45% |
| Vanbroekhoven (Annie) | 2.00K | 0.09% |
Short interest
Settled Sep 30, 2026
- Shares short
- 71.16K
- Days to cover
- 1.00
- % of shares outstanding
- 3.12%
- Average daily volume
- 333.94K
- Change since last report
- +145.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.